Jerel A. Banks
CIK: 0001808930
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNTC
Benitec Biopharma Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Banks Jerel A.
Banks Jerel A. (SEC CIK 0001808930) files insider reports with the SEC as Chief Executive Officer of Benitec Biopharma Inc. (BNTC).
Signal8 holds 2 ownership filings by Banks Jerel A., all Form 4s, filed between Dec 11, 2024 and Nov 20, 2025. Those filings report 2 transactions, from Dec 9, 2024 to Nov 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Banks Jerel A.'s filings is in HAYWARD, CA.
Recent filings by Banks Jerel A.
Other insiders filing for Benitec Biopharma Inc. (BNTC)
- Friedman David Matthew, Director
- Mates Sharon, Director
- MONTANOVA CAPITAL, LLC, Director
- Mehta Kishan, Director
- Smith Edward F, Director
- Francis Peter, Director